Lung Cancer Panel 8: Your Path to Precision Treatment
When facing a lung cancer diagnosis, uncertainty can feel overwhelming. Our comprehensive Lung Cancer Panel 8 provides the clarity and confidence you need to make informed treatment decisions. This advanced genetic analysis examines six critical biomarkers that could unlock targeted therapy options specifically tailored to your unique cancer profile.
Understanding Your Lung Cancer Panel 8
This sophisticated test analyses six key genetic markers that play crucial roles in lung cancer development and treatment response:
- EGFR – Epidermal Growth Factor Receptor mutations
- BRAF – Key signaling pathway mutations
- ALK – Anaplastic Lymphoma Kinase rearrangements
- ROS – ROS1 gene fusions
- MET – MET amplification and mutations
- PDL1 – Programmed Death-Ligand 1 expression
Using advanced methods including FISH, Sanger Sequencing, and IHC, we provide comprehensive analysis of your tumor tissue to guide personalized treatment strategies.
Who Should Consider This Test?
This test is particularly important if you:
- Have been diagnosed with non-small cell lung cancer (NSCLC)
- Are experiencing persistent cough, chest pain, or breathing difficulties
- Have a family history of lung cancer
- Are a current or former smoker with concerning symptoms
- Need to determine eligibility for targeted therapies or immunotherapy
- Want to understand your cancer’s genetic profile for treatment planning
Early genetic profiling can significantly impact your treatment success and quality of life.
Why This Matters for Your Health Journey
Understanding your cancer’s genetic makeup transforms treatment from guesswork to precision:
- Personalized Treatment – Identify which targeted therapies will work best for your specific cancer type
- Avoid Ineffective Treatments – Prevent wasting time and resources on treatments unlikely to work
- Access New Options – Unlock eligibility for cutting-edge immunotherapies and targeted drugs
- Better Outcomes – Targeted treatments often have fewer side effects and better response rates
- Peace of Mind – Make confident decisions based on comprehensive genetic information
Understanding Your Results
Your comprehensive report will clearly explain:
- Which genetic mutations are present in your cancer
- How these mutations affect treatment options
- Specific targeted therapy recommendations
- Immunotherapy eligibility based on PDL1 expression
- Clear next steps for discussion with your oncologist
Our medical team is available to help you understand your results and discuss them with your healthcare provider.
Investment in Your Health
| Test Option | Price | Turnaround Time |
|---|---|---|
| Lung Cancer Panel 8 (Regular Price) | ZAR 20,000 | 5-7 days |
| Lung Cancer Panel 8 (Special Price) | ZAR 15,000 | 5-7 days |
This comprehensive genetic analysis could save you from costly, ineffective treatments and guide you toward therapies that actually work for your specific cancer.
Why Trust Oracle Genomics?
- Nationwide Coverage – Available across South Africa including Johannesburg, Cape Town, Durban, and Pretoria
- Medical Expertise – Conducted by experienced oncology specialists
- Advanced Technology – Using FISH, Sanger Sequencing, and IHC for maximum accuracy
- Quick Results – Comprehensive analysis in just 5-7 days
- Patient-Focused – Clear, understandable reporting and support
Test Requirements
Sample Type: Tumor tissue (paraffin embedded tissue blocks)
Prescription: Required from your doctor (not applicable for surgery, pregnancy, or travel abroad cases)
Methodology: FISH, Sanger Sequencing, IHC
Take Control of Your Treatment Journey Today
Don’t let uncertainty dictate your cancer treatment. With our Lung Cancer Panel 8, you gain the genetic insights needed for personalized, effective care. Every day matters in cancer treatment – take the first step toward precision medicine today.
Available nationwide – Serving patients in Johannesburg, Cape Town, Durban, Pretoria and across South Africa
